<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02308293</url>
  </required_header>
  <id_info>
    <org_study_id>End_lac_sympt</org_study_id>
    <nct_id>NCT02308293</nct_id>
  </id_info>
  <brief_title>The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia</brief_title>
  <official_title>The Effect of Exercise-induced Hyperlacticacidemia on Counterregulatory Responses, Symptoms, Cognitive Function and Brain Lactate Accumulation During Hypoglycemia in (Hypoglycemic Unaware)Type I Diabetes Patients and Normal Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Diabetes Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Foundation for the Study of Diabetes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iatrogenic hypoglycemia is the most frequent acute complication of insulin therapy in people
      with type 1 diabetes (T1DM). Recurrent hypoglycemic events initiate a process of habituation,
      characterized by suppression of hypoglycemic symptoms, eventually leading to hypoglycemia
      unawareness, which creates a particularly high risk of severe hypoglycemia. Recent evidence
      suggest a pivotal role for (brain) lactate in the pathogenesis of hypoglycemia unawareness.
      Indeed, exogenous lactate administration may preserve brain function and attenuate
      counterregulatory responses to and symptomatic awareness of hypoglycemia. It is unknown
      whether endogenous elevation of plasma lactate produces the same effects and whether such
      effects differ between patients with T1DM with and without hypoglycemia unawareness and
      healthy controls.

      Objective: To investigate the effect of elevated levels of endogenous lactate on brain
      lactate accumulation and on counterregulatory responses to, symptomatic awareness of and
      cognitive function during hypoglycemia in patients with T1DM with and without hypoglycemia
      unawareness and normal controls.

      Hypothesis: The investigators hypothesize first that endogenous lactate, when raised through
      high intensity exercise, preserves neuronal metabolism during subsequent hypoglycemia, which
      in turn will attenuate counterregulatory hormone responses, appearance of symptoms and
      deterioration of cognitive function. Second, the investigators posit that these effects will
      be augmented in patients with hypoglycemia unawareness compared to healthy subjects and T1DM
      patients with normal awareness as a consequence of greater transport capacity of lactate into
      the brain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma level of adrenaline in response to hypoglycemia (Adrenaline, measured in arterial plasma)</measure>
    <time_frame>during 60 m of hypoglycemia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma levels of other counter-regulatory hormones (Levels of counter-regulatory hormones measured in arterial plasma)</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>Levels of counter-regulatory hormones measured in arterial plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose infusion rate (Amount of glucose 20% necessary to maintain plasma glucose at steady state values)</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>Amount of glucose 20% necessary to maintain plasma glucose at steady state values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma lactate levels (Lactate levels measured in arterial plasma)</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>Lactate levels measured in arterial plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive functioning, as measured by cognitive tests</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>Cognitive test will be: Dutch State Trait Anxiety Inventory, Digit Span, Stroop color word test, word fluency test, trail making test and Pasat</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma levels of inflammatory markers (levels of cytokines)</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>levels of cytokines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain perfusion measured with ASL-MRI</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>Brain perfusion measured with ASL-MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain lactate accumulation measured with 1H-MRS</measure>
    <time_frame>During 60 min of hypoglycemia</time_frame>
    <description>Brain lactate levels measured with 1H-MRS</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Plasma glucose concentration</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>Plasma glucose concentration, necessary to adjust glucose infusion rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Plasma insulin concentration (Insulin levels, measured in arterial plasma)</measure>
    <time_frame>During 60 min hypoglycemia</time_frame>
    <description>Insulin levels, measured in arterial plasma</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Hypoglycemia Unawareness</condition>
  <arm_group>
    <arm_group_label>High intensity exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will preform a high intensity training exercise (3* 30 seconds all out sprint on a cycle ergometer) to raise plasma lactate levels</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lay down comfortably</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>As a control conditions, subjects wil lay down comfortably and rest</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High intensity exercise</intervention_name>
    <description>3x30 seconds 'all out' sprints</description>
    <arm_group_label>High intensity exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lay down comfortably</intervention_name>
    <description>rest</description>
    <arm_group_label>Lay down comfortably</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria for healthy subjects

          -  Age: 18-40 years

          -  Body-Mass Index: 18-30 kg/m2

          -  Blood pressure: &lt;160/90 mmHg

          -  Recreationally active: i.e. taking part in competitive sport or regular exercise
             training, of a non-professional nature, once or more a week.

        Inclusion criteria T1DM patients with normal hypoglycemic awareness

          -  Diabetes duration ≥ 1 year

          -  Age: 18-40 years

          -  Body-Mass Index: 18-30 kg/m2

          -  HbA1c: 42-75 mmol/mol (6-9%)

          -  Outcome Clarke questionnaire: 0-1

          -  Blood pressure: &lt;160/90 mmHg

          -  Recreationally active: i.e. taking part in competitive sport or regular exercise
             training, of a non-professional nature, once or more a week

        Inclusion criteria T1DM patients with hypoglycemia unawareness

          -  Diabetes duration ≥ 1 year

          -  Age: 18-40 years

          -  Body-Mass Index: 18-30 kg/m2

          -  HbA1c: 42-75 mmol/mol (6-9%)

          -  Outcome Clarke questionnaire: =&gt;3

          -  Blood pressure: &lt;160/90 mmHg

          -  Recreationally active

        Exclusion criteria:

          -  Inability to provide informed consent

          -  Presence of any medical condition that might interfere with the study protocol, such
             as brain injuries, epilepsy, a major cardiovascular disease event or anxiety disorders

          -  Use of any medication, except for oral contraceptives

          -  MR(I) contraindications (pregnancy, severe claustrophobia, metal parts in body)

          -  Orthopedic and/or neurological diseases that impair exercise

          -  Cardiopulmonary disease as stated in the 2001 American heart association and 2002
             American college of cardiology/American heart association guidelines

        Additional exclusion criteria for all T1DM patients:

          -  Use of any other medication than insulin, except for oral contraceptives or stable
             thyroxine supplementation therapy

          -  complications of T1DM, including proliferative retinopathy, neuropathy or nephropathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bastiaan de Galan, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud umc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud umc</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>van de Ven KC, van der Graaf M, Tack CJ, Klomp DW, Heerschap A, de Galan BE. Optimized [1-(13)C]glucose infusion protocol for 13C magnetic resonance spectroscopy at 3T of human brain glucose metabolism under euglycemic and hypoglycemic conditions. J Neurosci Methods. 2010 Jan 30;186(1):68-71. doi: 10.1016/j.jneumeth.2009.10.025. Epub 2009 Nov 11.</citation>
    <PMID>19913052</PMID>
  </reference>
  <reference>
    <citation>van de Ven KC, de Galan BE, van der Graaf M, Shestov AA, Henry PG, Tack CJ, Heerschap A. Effect of acute hypoglycemia on human cerebral glucose metabolism measured by ¹³C magnetic resonance spectroscopy. Diabetes. 2011 May;60(5):1467-73. doi: 10.2337/db10-1592. Epub 2011 Apr 4.</citation>
    <PMID>21464446</PMID>
  </reference>
  <reference>
    <citation>van de Ven KC, van der Graaf M, Tack CJ, Heerschap A, de Galan BE. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes. 2012 Aug;61(8):1974-7. doi: 10.2337/db11-1778. Epub 2012 Jun 11.</citation>
    <PMID>22688331</PMID>
  </reference>
  <reference>
    <citation>De Feyter HM, Mason GF, Shulman GI, Rothman DL, Petersen KF. Increased brain lactate concentrations without increased lactate oxidation during hypoglycemia in type 1 diabetic individuals. Diabetes. 2013 Sep;62(9):3075-80. doi: 10.2337/db13-0313. Epub 2013 May 28.</citation>
    <PMID>23715622</PMID>
  </reference>
  <reference>
    <citation>Maddock RJ, Casazza GA, Buonocore MH, Tanase C. Vigorous exercise increases brain lactate and Glx (glutamate+glutamine): a dynamic 1H-MRS study. Neuroimage. 2011 Aug 15;57(4):1324-30. doi: 10.1016/j.neuroimage.2011.05.048. Epub 2011 May 27.</citation>
    <PMID>21640838</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2014</study_first_submitted>
  <study_first_submitted_qc>December 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>November 23, 2016</last_update_submitted>
  <last_update_submitted_qc>November 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 1 Diabetes Mellitus</keyword>
  <keyword>Hypoglycemia unawareness</keyword>
  <keyword>Lactate</keyword>
  <keyword>high intensity interval exercise</keyword>
  <keyword>MRS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Unconsciousness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

